![Daily Recap](https://gallery.mailchimp.com/f8609630ae206654824f897b6/images/bc09de95-1113-49ec-bcfb-ed1b1eef8800.png)
STAT Plus: AbbVie is sued for using Humira patent deals to block competition in the U.S.
DAVID J. PHILLIP/AP
The patent deals restrict the other drug makers from selling biosimilar versions of Humira in the U.S. until 2023, but sales are permitted in Europe
No hay comentarios:
Publicar un comentario